Treosulfan Completed Phase 2 Trials for Prostate Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00427999Combined Antiinflammatory and Angiostatic Therapy in Patients With Hormone-refractory Prostate Cancer